Health - U.S. clears new version of Novo Nordisk clot therapy
5/9/2008 2:12:54 PM
WASHINGTON (Reuters) - Denmarks Novo Nordisk won U.S. approval to sell a new formulation of a genetically engineered protein therapy that helps the blood clot, regulators said on Friday.
...
full article